How soon do you see results with Wegovy?

What happens in the first few weeks, and why the scales may not move yet?

A question our prescribers hear most weeks: 'I've been injecting for a fortnight and I've only lost a pound, is it working?' The short answer is almost certainly yes. Wegovy starts at 0.25mg, a dose designed to let your body adjust rather than drive immediate loss. At that level, the medicine is settling into its rhythm, slowing gastric emptying, signalling fullness earlier, beginning to recalibrate appetite. The weight loss, when it comes, follows; it doesn't usually arrive first.

What people often notice before the scales shift is a change in how food feels. Portions that once seemed normal start feeling like too much. The impulse to snack after dinner fades. These early signals matter because they confirm the medicine is doing what it should. They're also, practically speaking, how the calorie reduction begins, not through discipline alone, but through altered hunger.

For a fuller picture of what to expect in those opening weeks, the timeline of how long Wegovy takes to work covers the dose-by-dose picture in more detail. The NHS also provides a patient-level overview of semaglutide at NHS.uk.

When does noticeable weight loss typically appear?

Based on trial data, the 8-to-12-week window is when most people begin to see changes they'd describe as noticeable. By that point, the dose has usually moved from 0.25mg to 0.5mg or 1mg, and the medicine is working more consistently on appetite and energy regulation. The pattern of weight loss with Wegovy isn't a straight line downward; it tends to step with the titration schedule, speeding up after each dose increase before settling again.

In STEP 1, the average 15% body-weight reduction accumulated over 68 weeks. That means the full result isn't a first-month event, it's a trajectory. Someone weighing 100kg might lose around 3–5kg in the first two months, then continue losing at a slower but sustained rate as treatment progresses. Individual variation is real: metabolism, starting weight, how closely someone can follow dietary guidance, and their physical activity all shape the pace. If you want to understand how soon you can expect to see results from Wegovy, it helps to look at the evidence across the full titration period rather than the first few weeks alone. What trials give us is an average, not a guarantee.

If weight loss feels slower than expected, the first conversation should always be with a prescriber. Dose timing, injection technique and whether GI side effects are affecting eating all play a role, and all are worth reviewing.

Does the dose you're on change how quickly results appear?

Yes, and this is one of the more underappreciated parts of the Wegovy journey. The titration pathway (0.25mg, 0.5mg, 1.0mg, 1.7mg, then 2.4mg maintenance) isn't just a safety measure. Each step up in dose typically brings a renewed period of appetite reduction and, with it, faster weight loss. People often describe their results feeling like they 'restart' after each increase. Our guide on how fast you see results with Wegovy explores how each dose stage tends to affect the pace of loss in practice.

The MHRA has also approved a higher 7.2mg maintenance dose, with trials showing around 20.7% average weight loss over 72 weeks, closer to what tirzepatide produces at its highest dose. If you're curious how that compares to other treatments, our weight-loss treatments overview sets out what's currently licensed in the UK. For those specifically researching the 7.2mg pen approval, the MHRA's announcement from April 2026 covers the clinical background.

The upshot: results build across the full treatment course. Judging Wegovy at four weeks, on a starter dose, is a bit like judging a run before you've warmed up.

What affects whether someone sees results sooner or later?

Several factors shape the pace of results, and it's worth being honest about them. Diet matters: Wegovy reduces appetite, but if eating habits don't shift at all, the calorie deficit it creates is smaller. Physical activity supports muscle retention during weight loss, which affects how the change looks and feels. Starting BMI plays a role too, people with a higher starting weight often see faster absolute losses, though the percentage reduction tends to even out over time.

There are also factors that have nothing to do with effort: how an individual metabolises the medicine, whether GI side effects have been significant enough to affect food intake in a chaotic rather than intentional way, and whether any concurrent medications interact. If you're weighing up your own situation, our page on how soon you will see results from Wegovy sets out the personal variables that tend to make the biggest difference. A prescriber can look at the full picture.

NICE's guidance on semaglutide (TA875) notes that if less than 5% weight loss has occurred after six months on the maintenance dose, continuing treatment should be reviewed. That's not a deadline, it's a checkpoint, and one that requires clinical input rather than a self-assessment. If you're thinking about starting, our Wegovy information page covers eligibility and what the consultation involves. You can also explore all available treatments and check your eligibility through a free consultation with our prescribers.